Tech Company Financing Transactions

Clarus Therapeutics Funding Round

Clarus Therapeutics, based in Northbrook, secured $1.4 million from Thomas and McNerny & Partners.

Transaction Overview

Announced On
6/30/2009
Transaction Type
Venture Equity
Amount
$1,350,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
555 Skokie Blvd. 340
Northbrook, IL 60062
USA
Email Address
Overview
Clarus Therapeutics is an emerging men s health specialty pharmaceutical company preparing for the commercial launch of REXTORO, our oral testosterone (T) replacement therapy.
Profile
Clarus Therapeutics LinkedIn Company Profile
Social Media
Clarus Therapeutics Company Twitter Account
Company News
Clarus Therapeutics News
Facebook
Clarus Therapeutics on Facebook
YouTube
Clarus Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Dudley
  Robert Dudley LinkedIn Profile  Robert Dudley Twitter Account  Robert Dudley News  Robert Dudley on Facebook
Chief Financial Officer
Steven Bourne
  Steven Bourne LinkedIn Profile  Steven Bourne Twitter Account  Steven Bourne News  Steven Bourne on Facebook
Chief Medical Officer
Theodore Danoff
  Theodore Danoff LinkedIn Profile  Theodore Danoff Twitter Account  Theodore Danoff News  Theodore Danoff on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2009: GlobeImmune venture capital transaction
Next: 6/30/2009: BodyMedia venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary